| 1 | 8523269 | [Screening of phagocyte activators in plants; enhancement of TNF production by flavonoids]. | Yakugaku Zasshi | 1995 Sep |
1 |
| 2 | 8924586 | Inhibition of thyroid peroxidase by dietary flavonoids. | Chem Res Toxicol | 1996 Jan-Feb |
1 |
| 3 | 9480906 | Protein serine/threonine phosphatase inhibitors suppress phenobarbital-induced Cyp2b10 gene transcription in mouse primary hepatocytes. | Biochem J | 1998 Mar 1 |
1 |
| 4 | 9821810 | Inhibition of vinblastine efflux mediated by P-glycoprotein by grapefruit juice components in caco-2 cells. | Biol Pharm Bull | 1998 Oct |
1 |
| 5 | 9875509 | Intestinal bacterial metabolism of flavonoids and its relation to some biological activities. | Arch Pharm Res | 1998 Feb |
1 |
| 6 | 10193661 | Suppression of lipopolysaccharide-induced tumor necrosis factor-release and liver injury in mice by naringin. | Eur J Pharmacol | 1999 Mar 5 |
2 |
| 7 | 11396955 | Anti-atherogenic effect of citrus flavonoids, naringin and naringenin, associated with hepatic ACAT and aortic VCAM-1 and MCP-1 in high cholesterol-fed rabbits. | Biochem Biophys Res Commun | 2001 Jun 15 |
7 |
| 8 | 11506811 | Inhibitory effect of naringin on the micronuclei induced by ifosfamide in mouse, and evaluation of its modulatory effect on the Cyp3a subfamily. | Mutat Res | 2001 Sep 1 |
2 |
| 9 | 11707699 | Naringin has an antiatherogenic effect with the inhibition of intercellular adhesion molecule-1 in hypercholesterolemic rabbits. | J Cardiovasc Pharmacol | 2001 Dec |
5 |
| 10 | 11720089 | Antioxidative activity of naringin and lovastatin in high cholesterol-fed rabbits. | Life Sci | 2001 Nov 2 |
3 |
| 11 | 11737987 | Inhibition of human CYP3A4 activity by grapefruit flavonoids, furanocoumarins and related compounds. | J Pharm Pharm Sci | 2001 Sep-Dec |
1 |
| 12 | 11814474 | Comparison of antioxidant effects of naringin and probucol in cholesterol-fed rabbits. | Clin Chim Acta | 2002 Mar |
3 |
| 13 | 12095991 | Naringin-sensitive phosphorylation of plectin, a cytoskeletal cross-linking protein, in isolated rat hepatocytes. | J Biol Chem | 2002 Sep 20 |
3 |
| 14 | 12405759 | Determination of naringin in rat blood, brain, liver, and bile using microdialysis and its interaction with cyclosporin a, a p-glycoprotein modulator. | J Agric Food Chem | 2002 Nov 6 |
2 |
| 15 | 12576520 | Modulation by flavonoids of PAF and related phospholipids in endothelial cells during oxidative stress. | J Lipid Res | 2003 Feb |
1 |
| 16 | 12967034 | Naringin and naringenin inhibit nitrite-induced methemoglobin formation. | Pharmazie | 2003 Aug |
2 |
| 17 | 14765287 | Suppression of infection-induced endotoxin shock in mice by a citrus flavanone naringin. | Planta Med | 2004 Jan |
1 |
| 18 | 15231453 | Flavonoids promote cell migration in nontumorigenic colon epithelial cells differing in Apc genotype: implications of matrix metalloproteinase activity. | Nutr Cancer | 2004 |
1 |
| 19 | 15342961 | Toxin-induced tail phosphorylation of hepatocellular S6 kinase: evidence for a dual involvement of the AMP-activated protein kinase in S6 kinase regulation. | Toxicol Sci | 2004 Dec |
1 |
| 20 | 15380892 | Antihypercholesterolemic property of naringin alters plasma and tissue lipids, cholesterol-regulating enzymes, fecal sterol and tissue morphology in rabbits. | Clin Nutr | 2004 Oct |
1 |
| 21 | 15618000 | CYP1A1 genotype-selective inhibition of benzo[a]pyrene activation by quercetin. | Eur J Cancer | 2005 Jan |
1 |
| 22 | 15911222 | Modulation of drug transport by selected flavonoids: Involvement of P-gp and OCT? | Eur J Pharm Sci | 2005 Jun |
1 |
| 23 | 15936352 | Modulation of radiation-induced alteration in the antioxidant status of mice by naringin. | Life Sci | 2005 Jul 1 |
1 |
| 24 | 17009338 | Effects of naringin on the pharmacokinetics of intravenous paclitaxel in rats. | Biopharm Drug Dispos | 2006 Dec |
6 |
| 25 | 17188415 | Preventive effect of naringin on cardiac markers, electrocardiographic patterns and lysosomal hydrolases in normal and isoproterenol-induced myocardial infarction in Wistar rats. | Toxicology | 2007 Feb 12 |
3 |
| 26 | 17532169 | HPLC separation of naringin, neohesperidin and their C-2 epimers in commercial samples and herbal medicines. | J Pharm Biomed Anal | 2008 Apr 14 |
1 |
| 27 | 17846099 | Riboflavin-binding protein is a novel bitter inhibitor. | Chem Senses | 2008 Jan |
1 |
| 28 | 17876860 | Inhibitory effects of various beverages on human recombinant sulfotransferase isoforms SULT1A1 and SULT1A3. | Biopharm Drug Dispos | 2007 Dec |
1 |
| 29 | 18296682 | Requirement for Ras/Raf/ERK pathway in naringin-induced G1-cell-cycle arrest via p21WAF1 expression. | Carcinogenesis | 2008 Sep |
12 |
| 30 | 18451520 | Comparative evaluation of 12 immature citrus fruit extracts for the inhibition of cytochrome P450 isoform activities. | Biol Pharm Bull | 2008 May |
1 |
| 31 | 18495116 | Naringin-induced bone morphogenetic protein-2 expression via PI3K, Akt, c-Fos/c-Jun and AP-1 pathway in osteoblasts. | Eur J Pharmacol | 2008 Jul 7 |
8 |
| 32 | 18803250 | Citrus fruit flavonoids influence on neutrophil apoptosis and oxidative metabolism. | Phytother Res | 2008 Dec |
1 |
| 33 | 18951945 | Naringin-induced p21WAF1-mediated G(1)-phase cell cycle arrest via activation of the Ras/Raf/ERK signaling pathway in vascular smooth muscle cells. | Food Chem Toxicol | 2008 Dec |
6 |
| 34 | 19002566 | Concentration-dependent effect of naringin on intestinal absorption of beta(1)-adrenoceptor antagonist talinolol mediated by p-glycoprotein and organic anion transporting polypeptide (Oatp). | Pharm Res | 2009 Mar |
1 |
| 35 | 19323275 | Modulation of anticancer drug-induced P-glycoprotein expression by naringin. | Z Naturforsch C J Biosci | 2009 Jan-Feb |
1 |
| 36 | 19577560 | Protective effect of naringin against ischemic reperfusion cerebral injury: possible neurobehavioral, biochemical and cellular alterations in rat brain. | Eur J Pharmacol | 2009 Aug 15 |
1 |
| 37 | 19779132 | Species difference in the effect of grapefruit juice on intestinal absorption of talinolol between human and rat. | J Pharmacol Exp Ther | 2010 Jan |
14 |
| 38 | 19810018 | Naringin inhibits matrix metalloproteinase-9 expression and AKT phosphorylation in tumor necrosis factor-alpha-induced vascular smooth muscle cells. | Mol Nutr Food Res | 2009 Dec |
8 |
| 39 | 19885011 | Naringin Protects against Rotenone-induced Apoptosis in Human Neuroblastoma SH-SY5Y Cells. | Korean J Physiol Pharmacol | 2009 Aug |
10 |
| 40 | 20159712 | [Naringin inhibits monocyte adhesion to high glucose-induced human umbilical vein endothelial cells]. | Nan Fang Yi Ke Da Xue Xue Bao | 2010 Feb |
2 |
| 41 | 20660284 | The citrus flavonoids hesperidin and naringin do not affect serum cholesterol in moderately hypercholesterolemic men and women. | J Nutr | 2010 Sep |
2 |
| 42 | 20673063 | Protective effect of naringin, a citrus flavonoid, against colchicine-induced cognitive dysfunction and oxidative damage in rats. | J Med Food | 2010 Aug |
3 |
| 43 | 20684240 | [New non-peptide inhibitors of furin]. | Ukr Biokhim Zh (1999) | 2010 Mar-Apr |
1 |
| 44 | 20686826 | Intestinal absorption of HMG-CoA reductase inhibitor pravastatin mediated by organic anion transporting polypeptide. | Pharm Res | 2010 Oct |
1 |
| 45 | 20691757 | Protective effects of the citrus flavanones to PC12 cells against cytotoxicity induced by hydrogen peroxide. | Neurosci Lett | 2010 Oct 22 |
1 |
| 46 | 21206133 | Intestinal absorption of HMG-CoA reductase inhibitor pitavastatin mediated by organic anion transporting polypeptide and P-glycoprotein/multidrug resistance 1. | Drug Metab Pharmacokinet | 2011 |
1 |
| 47 | 21372385 | Naringin protects against kainic acid-induced status epilepticus in rats: evidence for an antioxidant, anti-inflammatory and neuroprotective intervention. | Biol Pharm Bull | 2011 |
1 |
| 48 | 21500970 | Inhibition of TNF-α/IFN-γ induced RANTES expression in HaCaT cell by naringin. | Pharm Biol | 2011 Aug |
3 |
| 49 | 21535545 | Evaluation of antioxidant and inhibitory activities for different subclasses flavonoids on enzymes for rheumatoid arthritis. | J Food Sci | 2010 Sep |
2 |
| 50 | 21633340 | Pharmacokinetic impact of SLCO1A2 polymorphisms on imatinib disposition in patients with chronic myeloid leukemia. | Clin Pharmacol Ther | 2011 Jul |
2 |